Waldencast plc (NASDAQ:WALD - Get Free Report) was up 5.7% during mid-day trading on Monday . The company traded as high as $5.77 and last traded at $5.77. Approximately 1,081 shares were traded during trading, a decline of 98% from the average daily volume of 68,997 shares. The stock had previously closed at $5.46.
Analyst Upgrades and Downgrades
Separately, Telsey Advisory Group cut their price target on Waldencast from $12.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, March 22nd.
View Our Latest Report on Waldencast
Waldencast Stock Performance
The firm has a 50 day simple moving average of $6.68 and a two-hundred day simple moving average of $8.34.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in the company. Amalgamated Bank increased its stake in Waldencast by 68.1% in the 3rd quarter. Amalgamated Bank now owns 3,277 shares of the company's stock valued at $31,000 after buying an additional 1,328 shares during the last quarter. Barclays PLC lifted its holdings in Waldencast by 75.3% during the third quarter. Barclays PLC now owns 7,177 shares of the company's stock worth $67,000 after acquiring an additional 3,084 shares during the period. SG Americas Securities LLC boosted its position in Waldencast by 23.2% in the fourth quarter. SG Americas Securities LLC now owns 19,705 shares of the company's stock worth $216,000 after purchasing an additional 3,716 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in Waldencast by 44.4% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 16,226 shares of the company's stock worth $178,000 after purchasing an additional 4,992 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System bought a new position in Waldencast in the 3rd quarter valued at $97,000. 41.97% of the stock is owned by institutional investors.
Waldencast Company Profile
(
Get Free Report)
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Featured Stories
Before you consider Waldencast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waldencast wasn't on the list.
While Waldencast currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
